Professor Gareth EvansProfessor in Medical Genetics and Cancer Epidemiology
Qualifications: MD FRCP
Registration: GMC 2818946
Professional Bodies: Member and ex-Council Member of the Clinical Genetics Society, ex officio Chairman of the Cancer Genetics Group, Member and ex-Council Member of the British Society for Genetic Medicine
Role: Consultant Cancer Geneticist
Contact: +44161 701 5104; Fax: +44 161 276 6145
Professor Evans trained at St Mary’s Hospital Medical School, London (1978-83). He held a RAMC Cadetship (1980). He has established a national and international reputation in clinical and research aspects of cancer genetics, particularly in neurofibromatosis and breast cancer. He has developed a clinical service for cancer genetics in the North West Region of England, which is nationally regarded. He is an important opinion leader nationally through membership of committees and was chairman of the NICE Familial Breast Cancer Guideline Development Group (2002-2010) and is now clinical lead (2011-). He lectures throughout the UK and internationally on hereditary breast cancer and cancer syndromes. He has developed a national training program for clinicians, nurses and genetic counsellors in breast cancer genetics and established a system for risk assessment and counselling for breast cancer.
He has published 477 peer reviewed research publications; 182 as first or senior author. He has published over 75 reviews and chapters and has had a book published by Oxford University Press on familial cancer. He has an ISI web of knowledge H-index of 67 having only published his first article in 1990. In the last 5 years he has raised over £10 million in grants for multicentre and local studies – approximately £5 million to Manchester. He is Chief Investigator on a £1.59 million NIHR program grant (2009-2014) on breast cancer risk prediction.
Clinics: General cancer genetics clinics at Central Manchester and The Christie. Breast cancer family history and prevention clinic at the Genesis Prevention Centre and Wythenshawe Hospital. Leads the National Neurofibromatosis type 2 service and participates in three Multidisciplinary Team Meetings/ clinics monthly. He also works in the National Complex NF1 service undertaking clinics on atypical neurofibromatosis.